Presentation ESC 2016 Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation Presenter: Andreas Goette August 30, 2016
News Conference News ESC 2016 NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months Michael O'Riordan August 28, 2016
Presentation Outcomes of Patients With Atrial Fibrillation Undergoing PCI Presenter: NR. Sutton August 24, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Industry News Biosense Webster, Inc. Announces U.S. Launch of THERMOCOOL SMARTTOUCH® SF Catheter August 15, 2016
News Industry News Abbott Announces Positive Clinical Results from Studies of FIRM-Guided Rotor Ablation for Atrial Fibrillation June 22, 2016
News Industry News AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study June 21, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Industry News Cardiome Announces the Launch of ESMOCARD Solution for Injection in France May 12, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Daily News Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA Todd Neale April 21, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016
News Daily News Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends L.A. McKeown April 21, 2016
News Industry News Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days April 20, 2016
News Industry News Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor April 12, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Industry News CardioFocus' HeartLight® System Granted FDA Approval for Treatment of Atrial Fibrillation (AF) April 04, 2016
News Industry News Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment March 28, 2016